StockData
Bluejay Diagnostics, Inc. logo

Bluejay Diagnostics, Inc. (BJDX) stock

BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$2.15−0.14 (-5.90%)

Close on Nov 17, 2026Market cap $9.63MP/E –Yield –

Bluejay Diagnostics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Bluejay Diagnostics's price to sales ratio was 97.1× on Apr 28, 2023.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Apr 28, 202397.1×–

More Bluejay Diagnostics figures

See a number that looks wrong?